microRNAs in heart disease: putative novel therapeutic targets? - Test2 - elhamkhani - TriplyDB

microRNAs in heart disease: putative novel therapeutic targets?

microRNAs in heart disease: putative novel therapeutic targets?

http://www.wikidata.org/entity/Q33728265

about

Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143 microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment Methodological challenges in utilizing miRNAs as circulating biomarkers Novel concepts in HDL pharmacology.LIPCAR: a mitochondrial lnc in the noncoding RNA chain?Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the Normative Aging Study The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.BAF60 A, B, and Cs of muscle determination and renewal.MicroRNAs and lipoproteins: a connection beyond atherosclerosis?Paracrine mechanisms of stem cell reparative and regenerative actions in the heart Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction Restriction of big hearts by a small RNA MicroRNAs in cardiac disease MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation.Cardiac insulin resistance and microRNA modulators.Transcriptome microRNA profiling of bovine mammary glands infected with Staphylococcus aureus.Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor.Cardiac biomarkers in the intensive care unit Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.Biological significance of miR-126 expression in atrial fibrillation and heart failure.Induced pluripotent stem cells in cardiovascular drug discovery.Regulation of cardiac microRNAs by cardiac microRNAs.Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.MicroRNAs: redefining mechanisms in cardiac disease Atrial remodeling in atrial fibrillation and some related microRNAs.Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets.Circulating miRNAs: novel biomarkers of acute coronary syndrome?From cell phenotype to epigenetic mechanisms: new insights into regenerating myocardium.MiR-30e attenuates isoproterenol-induced cardiac fibrosis through suppressing Snai1/TGFβ signaling.Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling.Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?Implication of microRNAs in the development and potential treatment of radiation-induced heart disease.Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity.

P2860

Q24297012-87963DCF-B164-46FD-BEF2-27EB34B48204 Q26778918-2D5EA37F-EC1D-4DE0-BE29-B725B2598C53 Q27027950-B441F2DF-AB3F-4200-8971-D7814BF30C05 Q27692691-1976BB10-669E-413D-9917-1585F66401E7 Q28658644-EEE51877-138C-4B32-929A-5D79543B555C Q28743221-0484FA0A-4F0A-4E6D-997C-4933E5B51B5E Q30250314-1E733B19-2881-4E2D-8E67-122D2A53CC96 Q34316322-FAFC3033-76F2-4E2B-A543-B00212E7F848 Q34321706-2271C407-24DC-4D51-814F-60CD65880756 Q34494230-CDCEDC5C-DDB6-4D1C-965B-74627849254F Q34510584-4E3F1006-8DE3-497D-85CC-B32FC7FACB57 Q34626781-5D57A197-6459-44DE-BB96-EE46F20F6D54 Q34760006-384422CA-7887-4AD4-B4FD-4A40717FF5A7 Q34794475-3336D0E3-747A-4264-AC48-93A46FF3E4A7 Q35251097-20E1DAB3-4CFB-49CD-9E67-85ECB99526C1 Q35380721-665FE01D-C17A-414F-8354-624A570898A3 Q35601437-69423202-9A1F-4EF7-AB02-B83EA8E74BFB Q35856435-D00C13E0-BDD0-44D7-A472-83DFBBCA5C5E Q35976043-8FA6CD44-6CAE-489F-AA8C-A285B683E4E7 Q36351720-D552D408-D989-417E-8B91-83C270DBEF63 Q36996592-CBB59C7F-CBED-4639-B721-8B33F5E7760D Q37162692-6E863EAD-349D-442D-A075-F8EAC5C977D5 Q37294594-83C60CD7-5878-4C08-B331-77FA31DC5FE3 Q37538441-24422432-7CF6-4E33-B7B7-A2EACB4F8AA9 Q37544984-FCBF167B-2725-4506-B551-2E18E2C20F55 Q37685243-4649AAF2-DB6E-45F8-B2E3-51D6F1623016 Q37694630-166E9B2A-AC4F-4BC3-92D5-B78FF8D3471E Q37833881-6CEC09FC-931B-4D8C-B0CE-E44315CEF511 Q37969565-9E0F8200-2656-4DD3-99C7-75B47190A88B Q38044999-8BBEE1A9-A7E5-4CD7-9FFA-151111808316 Q38095110-CFFDACE8-CE33-45D6-8E1B-9651386D63CC Q38124390-2D180BD3-CEF5-40D8-8A9F-074C36B4A695 Q38641091-E4CDB0A9-93F7-407B-974F-8345AD2E7EB8 Q38835689-F5093C5F-6402-4BD3-B229-6982F9EDF863 Q38887635-41601FC0-92A3-4E74-9ACF-D7B756AB73E9 Q39193250-282B63B9-DA8B-4627-A5D7-F7173F7EB5DC Q39201286-0A3061F4-79F6-4FE1-A1F7-2EF5CAD75D50 Q39324079-9C18E20A-29A1-431D-BEBA-5CECAA50EE6A Q39415724-942A8E4C-4CC2-4988-9462-F8A255DF60AB Q41717594-23404C40-3F93-43D2-8C0D-F67E4961D3D2

P2860

microRNAs in heart disease: putative novel therapeutic targets?

http://www.wikidata.org/entity/Q33728265

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

microRNAs in heart disease: putative novel therapeutic targets?

@ast

microRNAs in heart disease: putative novel therapeutic targets?

@en

type

label

microRNAs in heart disease: putative novel therapeutic targets?

@ast

microRNAs in heart disease: putative novel therapeutic targets?

@en

prefLabel

microRNAs in heart disease: putative novel therapeutic targets?

@ast

microRNAs in heart disease: putative novel therapeutic targets?

@en

P1433

Q33728265-92FBD8DE-68EE-499F-9E58-C1D120022A57

P1476

Q33728265-796DF815-89A4-40DA-B3B1-C15272E89B50

P2093

Q33728265-3DCB698A-704B-4206-9060-3C515CE2500D

Q33728265-C8D2E015-F7CB-49B5-A447-01E5A4E411C8

P2860

Q33728265-01EFDEE4-D229-4E20-924D-6F49E0AC16CE

Q33728265-03CFBB67-BCE6-4186-A8DE-8802CD8D2E75

Q33728265-07F0ACCA-EA30-4D1F-9180-B52DB3CD537B

Q33728265-0C9981A6-E336-4635-B410-EC7C6C06B71C

Q33728265-0CB19497-225C-454B-9151-605B3AE821DE

Q33728265-0D6C093C-F62B-42A7-9CE1-47D99BB66347

Q33728265-11E0AD4B-6949-4733-8531-1F64BAF4C9DE

Q33728265-12554531-4ABA-4D5E-BD4D-8945DD0EBBA6

Q33728265-12583EFC-5086-45C7-A423-6DAFD7C2F6E3

Q33728265-12BAA551-F7E5-48F5-9103-C78C3561D893

P304

Q33728265-05B2A4D1-6E9D-40FF-BA22-7C883003F704

P31

Q33728265-325D4B20-053F-4079-9F5F-A7DC4A01FE07

P356

Q33728265-9C5F92AD-EB37-4167-86D5-B0B4C4C8566F

P433

Q33728265-0250CE1F-4896-4649-8CE5-2B5BDEABAD6D

P478

Q33728265-0FBC4565-C97B-4A4F-8FBB-2042EE7C0C09

P50

Q33728265-7B66AE00-931C-4A46-8B6D-BD315BBF9188

P577

Q33728265-8628BCCE-98E2-4EF5-92A0-A7254DA609A5

P5875

Q33728265-51F709AC-AAA4-4DCB-9D73-43B84CD7F3C0

P698

Q33728265-0A5F6B17-AE92-48E1-876D-610D31EF07A7

P921

Q33728265-AE8F9BBA-1E55-4131-84F7-B354C1AA048A

P932

Q33728265-ED7A8248-6683-4635-9944-963927AE6B15

P356

P1433

European Heart Journal

P1476

microRNAs in heart disease: putative novel therapeutic targets?

@en

P2093

Gerald W Dorn

http://www.w3.org/2001/XMLSchema#string

Michael V G Latronico

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear RNase III Drosha initiates microRNA processing

A human, ATP-independent, RISC assembly machine fueled by pre-miRNA

Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

miR-126 regulates angiogenic signaling and vascular integrity

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

MicroRNAs: target recognition and regulatory functions

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

P304

649-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHP573

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Gianluigi Condorelli

P577

2010-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41191229

http://www.w3.org/2001/XMLSchema#string

P698

20118173

http://www.w3.org/2001/XMLSchema#string

P921

P932

2838683

http://www.w3.org/2001/XMLSchema#string